The global market for Pharmaceutical Formulation Development Service was valued at US$ 1420 million in the year 2024 and is projected to reach a revised size of US$ 2099 million by 2031, growing at a CAGR of 5.6% during the forecast period.

Pharmaceutical Formulation Development Service Market

The Pharmaceutical Formulation Development Service is a systematic scientific research and technological development process whose core goal is to transform a bioactive pharmaceutical ingredient (API) into a safe, effective, and stable final dosage form suitable for industrial production and patient use. This service begins with in-depth characterization of the API's physicochemical properties, followed by scientific dosage form design and screening based on the target product's therapeutic needs, route of administration, and patient compliance. The development process encompasses key steps such as pre-formulation studies, excipient compatibility testing, formulation design and optimization, formulation process development, and pilot scale-up. Its core mission is not only to determine the optimal ratio of the active ingredient and various pharmaceutical excipients, but also to establish a robust and reliable manufacturing process and ensure that the final product meets predetermined quality standards, including key indicators such as dissolution, content uniformity, stability, and bioavailability. The entire development process strictly adheres to Quality by Design (QbD) principles and Good Manufacturing Practices (GMP) regulations, ultimately delivering a technical package including an optimized formulation, a mature process, quality control methods, and a comprehensive development report, providing critical support for subsequent production of the drug for clinical research and regulatory submission.

North American market for Pharmaceutical Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharmaceutical Formulation Development Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Pharmaceutical Formulation Development Service in Innovative Drug R&D Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Pharmaceutical Formulation Development Service include Adragos Pharma, Agno Pharma, Ascendia Pharmaceutical Solutions, Aurigene Pharmaceutical Services, Avivia, CMC Pharmaceuticals, Coriolis Pharma, Crystal Pharmatech, Eoltinplas Pharmaceutical Company, Intertek, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Formulation Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Formulation Development Service.

The Pharmaceutical Formulation Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Formulation Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pharmaceutical Formulation Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pharmaceutical Formulation Development Service Market Report

Report Metric	Details
Report Name	Pharmaceutical Formulation Development Service Market
Accounted market size in year	US$ 1420 million
Forecasted market size in 2031	US$ 2099 million
CAGR	5.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Poorly Soluble Drug Development Service Highly Permeable Drug Development Service Peptide/Protein Drug Development Service High-Dose Drug Development Service
Segment by Application	Innovative Drug R&D Companies Generic Drug Companies Improved New Drug Companies
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Adragos Pharma, Agno Pharma, Ascendia Pharmaceutical Solutions, Aurigene Pharmaceutical Services, Avivia, CMC Pharmaceuticals, Coriolis Pharma, Crystal Pharmatech, Eoltinplas Pharmaceutical Company, Intertek, LGM Pharma, Lonza, Lucideon, Scantox, Suven Pharma, Seda, Sharp Services, Kemwell Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Formulation Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Formulation Development Service Market growing?

Ans: The Pharmaceutical Formulation Development Service Market witnessing a CAGR of 5.6% during the forecast period 2025-2031.

What is the Pharmaceutical Formulation Development Service Market size in 2031?

Ans: The Pharmaceutical Formulation Development Service Market size in 2031 will be US$ 2099 million.

Who are the main players in the Pharmaceutical Formulation Development Service Market report?

Ans: The main players in the Pharmaceutical Formulation Development Service Market are Adragos Pharma, Agno Pharma, Ascendia Pharmaceutical Solutions, Aurigene Pharmaceutical Services, Avivia, CMC Pharmaceuticals, Coriolis Pharma, Crystal Pharmatech, Eoltinplas Pharmaceutical Company, Intertek, LGM Pharma, Lonza, Lucideon, Scantox, Suven Pharma, Seda, Sharp Services, Kemwell Pharma

What are the Application segmentation covered in the Pharmaceutical Formulation Development Service Market report?

Ans: The Applications covered in the Pharmaceutical Formulation Development Service Market report are Innovative Drug R&D Companies, Generic Drug Companies, Improved New Drug Companies

What are the Type segmentation covered in the Pharmaceutical Formulation Development Service Market report?

Ans: The Types covered in the Pharmaceutical Formulation Development Service Market report are Poorly Soluble Drug Development Service, Highly Permeable Drug Development Service, Peptide/Protein Drug Development Service, High-Dose Drug Development Service

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Poorly Soluble Drug Development Service

1.2.3 Highly Permeable Drug Development Service

1.2.4 Peptide/Protein Drug Development Service

1.2.5 High-Dose Drug Development Service

1.3 Market by Application

1.3.1 Global Pharmaceutical Formulation Development Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Innovative Drug R&D Companies

1.3.3 Generic Drug Companies

1.3.4 Improved New Drug Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pharmaceutical Formulation Development Service Market Perspective (2020-2031)

2.2 Global Pharmaceutical Formulation Development Service Growth Trends by Region

2.2.1 Global Pharmaceutical Formulation Development Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pharmaceutical Formulation Development Service Historic Market Size by Region (2020-2025)

2.2.3 Pharmaceutical Formulation Development Service Forecasted Market Size by Region (2026-2031)

2.3 Pharmaceutical Formulation Development Service Market Dynamics

2.3.1 Pharmaceutical Formulation Development Service Industry Trends

2.3.2 Pharmaceutical Formulation Development Service Market Drivers

2.3.3 Pharmaceutical Formulation Development Service Market Challenges

2.3.4 Pharmaceutical Formulation Development Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pharmaceutical Formulation Development Service Players by Revenue

3.1.1 Global Top Pharmaceutical Formulation Development Service Players by Revenue (2020-2025)

3.1.2 Global Pharmaceutical Formulation Development Service Revenue Market Share by Players (2020-2025)

3.2 Global Top Pharmaceutical Formulation Development Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pharmaceutical Formulation Development Service Revenue

3.4 Global Pharmaceutical Formulation Development Service Market Concentration Ratio

3.4.1 Global Pharmaceutical Formulation Development Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Formulation Development Service Revenue in 2024

3.5 Global Key Players of Pharmaceutical Formulation Development Service Head office and Area Served

3.6 Global Key Players of Pharmaceutical Formulation Development Service, Product and Application

3.7 Global Key Players of Pharmaceutical Formulation Development Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Formulation Development Service Breakdown Data by Type

4.1 Global Pharmaceutical Formulation Development Service Historic Market Size by Type (2020-2025)

4.2 Global Pharmaceutical Formulation Development Service Forecasted Market Size by Type (2026-2031)

5 Pharmaceutical Formulation Development Service Breakdown Data by Application

5.1 Global Pharmaceutical Formulation Development Service Historic Market Size by Application (2020-2025)

5.2 Global Pharmaceutical Formulation Development Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pharmaceutical Formulation Development Service Market Size (2020-2031)

6.2 North America Pharmaceutical Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pharmaceutical Formulation Development Service Market Size by Country (2020-2025)

6.4 North America Pharmaceutical Formulation Development Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pharmaceutical Formulation Development Service Market Size (2020-2031)

7.2 Europe Pharmaceutical Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pharmaceutical Formulation Development Service Market Size by Country (2020-2025)

7.4 Europe Pharmaceutical Formulation Development Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Pharmaceutical Formulation Development Service Market Size (2020-2031)

8.2 Asia-Pacific Pharmaceutical Formulation Development Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pharmaceutical Formulation Development Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Pharmaceutical Formulation Development Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Pharmaceutical Formulation Development Service Market Size (2020-2031)

9.2 Latin America Pharmaceutical Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pharmaceutical Formulation Development Service Market Size by Country (2020-2025)

9.4 Latin America Pharmaceutical Formulation Development Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pharmaceutical Formulation Development Service Market Size (2020-2031)

10.2 Middle East & Africa Pharmaceutical Formulation Development Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Adragos Pharma

11.1.1 Adragos Pharma Company Details

11.1.2 Adragos Pharma Business Overview

11.1.3 Adragos Pharma Pharmaceutical Formulation Development Service Introduction

11.1.4 Adragos Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.1.5 Adragos Pharma Recent Development

11.2 Agno Pharma

11.2.1 Agno Pharma Company Details

11.2.2 Agno Pharma Business Overview

11.2.3 Agno Pharma Pharmaceutical Formulation Development Service Introduction

11.2.4 Agno Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.2.5 Agno Pharma Recent Development

11.3 Ascendia Pharmaceutical Solutions

11.3.1 Ascendia Pharmaceutical Solutions Company Details

11.3.2 Ascendia Pharmaceutical Solutions Business Overview

11.3.3 Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Introduction

11.3.4 Ascendia Pharmaceutical Solutions Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.3.5 Ascendia Pharmaceutical Solutions Recent Development

11.4 Aurigene Pharmaceutical Services

11.4.1 Aurigene Pharmaceutical Services Company Details

11.4.2 Aurigene Pharmaceutical Services Business Overview

11.4.3 Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Introduction

11.4.4 Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.4.5 Aurigene Pharmaceutical Services Recent Development

11.5 Avivia

11.5.1 Avivia Company Details

11.5.2 Avivia Business Overview

11.5.3 Avivia Pharmaceutical Formulation Development Service Introduction

11.5.4 Avivia Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.5.5 Avivia Recent Development

11.6 CMC Pharmaceuticals

11.6.1 CMC Pharmaceuticals Company Details

11.6.2 CMC Pharmaceuticals Business Overview

11.6.3 CMC Pharmaceuticals Pharmaceutical Formulation Development Service Introduction

11.6.4 CMC Pharmaceuticals Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.6.5 CMC Pharmaceuticals Recent Development

11.7 Coriolis Pharma

11.7.1 Coriolis Pharma Company Details

11.7.2 Coriolis Pharma Business Overview

11.7.3 Coriolis Pharma Pharmaceutical Formulation Development Service Introduction

11.7.4 Coriolis Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.7.5 Coriolis Pharma Recent Development

11.8 Crystal Pharmatech

11.8.1 Crystal Pharmatech Company Details

11.8.2 Crystal Pharmatech Business Overview

11.8.3 Crystal Pharmatech Pharmaceutical Formulation Development Service Introduction

11.8.4 Crystal Pharmatech Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.8.5 Crystal Pharmatech Recent Development

11.9 Eoltinplas Pharmaceutical Company

11.9.1 Eoltinplas Pharmaceutical Company Company Details

11.9.2 Eoltinplas Pharmaceutical Company Business Overview

11.9.3 Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Introduction

11.9.4 Eoltinplas Pharmaceutical Company Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.9.5 Eoltinplas Pharmaceutical Company Recent Development

11.10 Intertek

11.10.1 Intertek Company Details

11.10.2 Intertek Business Overview

11.10.3 Intertek Pharmaceutical Formulation Development Service Introduction

11.10.4 Intertek Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.10.5 Intertek Recent Development

11.11 LGM Pharma

11.11.1 LGM Pharma Company Details

11.11.2 LGM Pharma Business Overview

11.11.3 LGM Pharma Pharmaceutical Formulation Development Service Introduction

11.11.4 LGM Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.11.5 LGM Pharma Recent Development

11.12 Lonza

11.12.1 Lonza Company Details

11.12.2 Lonza Business Overview

11.12.3 Lonza Pharmaceutical Formulation Development Service Introduction

11.12.4 Lonza Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.12.5 Lonza Recent Development

11.13 Lucideon

11.13.1 Lucideon Company Details

11.13.2 Lucideon Business Overview

11.13.3 Lucideon Pharmaceutical Formulation Development Service Introduction

11.13.4 Lucideon Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.13.5 Lucideon Recent Development

11.14 Scantox

11.14.1 Scantox Company Details

11.14.2 Scantox Business Overview

11.14.3 Scantox Pharmaceutical Formulation Development Service Introduction

11.14.4 Scantox Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.14.5 Scantox Recent Development

11.15 Suven Pharma

11.15.1 Suven Pharma Company Details

11.15.2 Suven Pharma Business Overview

11.15.3 Suven Pharma Pharmaceutical Formulation Development Service Introduction

11.15.4 Suven Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.15.5 Suven Pharma Recent Development

11.16 Seda

11.16.1 Seda Company Details

11.16.2 Seda Business Overview

11.16.3 Seda Pharmaceutical Formulation Development Service Introduction

11.16.4 Seda Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.16.5 Seda Recent Development

11.17 Sharp Services

11.17.1 Sharp Services Company Details

11.17.2 Sharp Services Business Overview

11.17.3 Sharp Services Pharmaceutical Formulation Development Service Introduction

11.17.4 Sharp Services Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.17.5 Sharp Services Recent Development

11.18 Kemwell Pharma

11.18.1 Kemwell Pharma Company Details

11.18.2 Kemwell Pharma Business Overview

11.18.3 Kemwell Pharma Pharmaceutical Formulation Development Service Introduction

11.18.4 Kemwell Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025)

11.18.5 Kemwell Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Adragos Pharma

Agno Pharma

Aurigene Pharmaceutical Services

Ascendia Pharmaceutical Solutions

Eoltinplas Pharmaceutical Company

List of Tables

Table 1. Global Pharmaceutical Formulation Development Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Poorly Soluble Drug Development Service

Table 3. Key Players of Highly Permeable Drug Development Service

Table 4. Key Players of Peptide/Protein Drug Development Service

Table 5. Key Players of High-Dose Drug Development Service

Table 6. Global Pharmaceutical Formulation Development Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pharmaceutical Formulation Development Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Pharmaceutical Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Pharmaceutical Formulation Development Service Market Share by Region (2020-2025)

Table 10. Global Pharmaceutical Formulation Development Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Pharmaceutical Formulation Development Service Market Share by Region (2026-2031)

Table 12. Pharmaceutical Formulation Development Service Market Trends

Table 13. Pharmaceutical Formulation Development Service Market Drivers

Table 14. Pharmaceutical Formulation Development Service Market Challenges

Table 15. Pharmaceutical Formulation Development Service Market Restraints

Table 16. Global Pharmaceutical Formulation Development Service Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Pharmaceutical Formulation Development Service Market Share by Players (2020-2025)

Table 18. Global Top Pharmaceutical Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Formulation Development Service as of 2024)

Table 19. Ranking of Global Top Pharmaceutical Formulation Development Service Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Pharmaceutical Formulation Development Service Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Pharmaceutical Formulation Development Service, Headquarters and Area Served

Table 22. Global Key Players of Pharmaceutical Formulation Development Service, Product and Application

Table 23. Global Key Players of Pharmaceutical Formulation Development Service, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pharmaceutical Formulation Development Service Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Pharmaceutical Formulation Development Service Revenue Market Share by Type (2020-2025)

Table 27. Global Pharmaceutical Formulation Development Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Pharmaceutical Formulation Development Service Revenue Market Share by Type (2026-2031)

Table 29. Global Pharmaceutical Formulation Development Service Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Pharmaceutical Formulation Development Service Revenue Market Share by Application (2020-2025)

Table 31. Global Pharmaceutical Formulation Development Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Pharmaceutical Formulation Development Service Revenue Market Share by Application (2026-2031)

Table 33. North America Pharmaceutical Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Pharmaceutical Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Pharmaceutical Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Pharmaceutical Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Pharmaceutical Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Pharmaceutical Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Pharmaceutical Formulation Development Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Pharmaceutical Formulation Development Service Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Pharmaceutical Formulation Development Service Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Pharmaceutical Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Pharmaceutical Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pharmaceutical Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Pharmaceutical Formulation Development Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Pharmaceutical Formulation Development Service Market Size by Country (2026-2031) & (US$ Million)

Table 48. Adragos Pharma Company Details

Table 49. Adragos Pharma Business Overview

Table 50. Adragos Pharma Pharmaceutical Formulation Development Service Product

Table 51. Adragos Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 52. Adragos Pharma Recent Development

Table 53. Agno Pharma Company Details

Table 54. Agno Pharma Business Overview

Table 55. Agno Pharma Pharmaceutical Formulation Development Service Product

Table 56. Agno Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 57. Agno Pharma Recent Development

Table 58. Ascendia Pharmaceutical Solutions Company Details

Table 59. Ascendia Pharmaceutical Solutions Business Overview

Table 60. Ascendia Pharmaceutical Solutions Pharmaceutical Formulation Development Service Product

Table 61. Ascendia Pharmaceutical Solutions Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 62. Ascendia Pharmaceutical Solutions Recent Development

Table 63. Aurigene Pharmaceutical Services Company Details

Table 64. Aurigene Pharmaceutical Services Business Overview

Table 65. Aurigene Pharmaceutical Services Pharmaceutical Formulation Development Service Product

Table 66. Aurigene Pharmaceutical Services Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 67. Aurigene Pharmaceutical Services Recent Development

Table 68. Avivia Company Details

Table 69. Avivia Business Overview

Table 70. Avivia Pharmaceutical Formulation Development Service Product

Table 71. Avivia Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 72. Avivia Recent Development

Table 73. CMC Pharmaceuticals Company Details

Table 74. CMC Pharmaceuticals Business Overview

Table 75. CMC Pharmaceuticals Pharmaceutical Formulation Development Service Product

Table 76. CMC Pharmaceuticals Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 77. CMC Pharmaceuticals Recent Development

Table 78. Coriolis Pharma Company Details

Table 79. Coriolis Pharma Business Overview

Table 80. Coriolis Pharma Pharmaceutical Formulation Development Service Product

Table 81. Coriolis Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 82. Coriolis Pharma Recent Development

Table 83. Crystal Pharmatech Company Details

Table 84. Crystal Pharmatech Business Overview

Table 85. Crystal Pharmatech Pharmaceutical Formulation Development Service Product

Table 86. Crystal Pharmatech Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 87. Crystal Pharmatech Recent Development

Table 88. Eoltinplas Pharmaceutical Company Company Details

Table 89. Eoltinplas Pharmaceutical Company Business Overview

Table 90. Eoltinplas Pharmaceutical Company Pharmaceutical Formulation Development Service Product

Table 91. Eoltinplas Pharmaceutical Company Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 92. Eoltinplas Pharmaceutical Company Recent Development

Table 93. Intertek Company Details

Table 94. Intertek Business Overview

Table 95. Intertek Pharmaceutical Formulation Development Service Product

Table 96. Intertek Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 97. Intertek Recent Development

Table 98. LGM Pharma Company Details

Table 99. LGM Pharma Business Overview

Table 100. LGM Pharma Pharmaceutical Formulation Development Service Product

Table 101. LGM Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 102. LGM Pharma Recent Development

Table 103. Lonza Company Details

Table 104. Lonza Business Overview

Table 105. Lonza Pharmaceutical Formulation Development Service Product

Table 106. Lonza Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 107. Lonza Recent Development

Table 108. Lucideon Company Details

Table 109. Lucideon Business Overview

Table 110. Lucideon Pharmaceutical Formulation Development Service Product

Table 111. Lucideon Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 112. Lucideon Recent Development

Table 113. Scantox Company Details

Table 114. Scantox Business Overview

Table 115. Scantox Pharmaceutical Formulation Development Service Product

Table 116. Scantox Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 117. Scantox Recent Development

Table 118. Suven Pharma Company Details

Table 119. Suven Pharma Business Overview

Table 120. Suven Pharma Pharmaceutical Formulation Development Service Product

Table 121. Suven Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 122. Suven Pharma Recent Development

Table 123. Seda Company Details

Table 124. Seda Business Overview

Table 125. Seda Pharmaceutical Formulation Development Service Product

Table 126. Seda Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 127. Seda Recent Development

Table 128. Sharp Services Company Details

Table 129. Sharp Services Business Overview

Table 130. Sharp Services Pharmaceutical Formulation Development Service Product

Table 131. Sharp Services Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 132. Sharp Services Recent Development

Table 133. Kemwell Pharma Company Details

Table 134. Kemwell Pharma Business Overview

Table 135. Kemwell Pharma Pharmaceutical Formulation Development Service Product

Table 136. Kemwell Pharma Revenue in Pharmaceutical Formulation Development Service Business (2020-2025) & (US$ Million)

Table 137. Kemwell Pharma Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

Table 141. Authors List of This Report

List of Figures

Figure 1. Pharmaceutical Formulation Development Service Picture

Figure 2. Global Pharmaceutical Formulation Development Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pharmaceutical Formulation Development Service Market Share by Type: 2024 VS 2031

Figure 4. Poorly Soluble Drug Development Service Features

Figure 5. Highly Permeable Drug Development Service Features

Figure 6. Peptide/Protein Drug Development Service Features

Figure 7. High-Dose Drug Development Service Features

Figure 8. Global Pharmaceutical Formulation Development Service Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Pharmaceutical Formulation Development Service Market Share by Application: 2024 VS 2031

Figure 10. Innovative Drug R&D Companies Case Studies

Figure 11. Generic Drug Companies Case Studies

Figure 12. Improved New Drug Companies Case Studies

Figure 13. Pharmaceutical Formulation Development Service Report Years Considered

Figure 14. Global Pharmaceutical Formulation Development Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Pharmaceutical Formulation Development Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Pharmaceutical Formulation Development Service Market Share by Region: 2024 VS 2031

Figure 17. Global Pharmaceutical Formulation Development Service Market Share by Players in 2024

Figure 18. Global Pharmaceutical Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Formulation Development Service Revenue in 2024

Figure 20. North America Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Pharmaceutical Formulation Development Service Market Share by Country (2020-2031)

Figure 22. United States Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Pharmaceutical Formulation Development Service Market Share by Country (2020-2031)

Figure 26. Germany Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Ireland Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Pharmaceutical Formulation Development Service Market Share by Region (2020-2031)

Figure 34. China Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia & New Zealand Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Pharmaceutical Formulation Development Service Market Share by Country (2020-2031)

Figure 42. Mexico Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Pharmaceutical Formulation Development Service Market Share by Country (2020-2031)

Figure 46. Israel Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Pharmaceutical Formulation Development Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Adragos Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 50. Agno Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 51. Ascendia Pharmaceutical Solutions Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 52. Aurigene Pharmaceutical Services Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 53. Avivia Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 54. CMC Pharmaceuticals Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 55. Coriolis Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 56. Crystal Pharmatech Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 57. Eoltinplas Pharmaceutical Company Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 58. Intertek Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 59. LGM Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 60. Lonza Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 61. Lucideon Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 62. Scantox Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 63. Suven Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 64. Seda Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 65. Sharp Services Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 66. Kemwell Pharma Revenue Growth Rate in Pharmaceutical Formulation Development Service Business (2020-2025)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions